PlanTradePlanMM

EVOK Long

看多
NASDAQ:EVOK   Evoke Pharma, Inc.
Price above SMA13
OBV>OBV34
WR > -80

Entry 1.4
Stop 1
Target 3.7

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
交易進行:
BuyToOpen (BTO) 2022 C2.5 0.3x10
Prepare to sell C5
No Stop
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。